254 related articles for article (PubMed ID: 8450211)
21. A novel HLA class II molecule (DR alpha-DQ beta) created by mismatched isotype pairing.
Lotteau V; Teyton L; Burroughs D; Charron D
Nature; 1987 Sep 24-30; 329(6137):339-41. PubMed ID: 3306409
[TBL] [Abstract][Full Text] [Related]
22. The nonpolymorphic MHC class II isotype, HLA-DQA2, is expressed on the surface of B lymphoblastoid cells.
Rudy GB; Lew AM
J Immunol; 1997 Mar; 158(5):2116-25. PubMed ID: 9036956
[TBL] [Abstract][Full Text] [Related]
23. HLA-DQB1 alleles may influence the surface expression of DQ molecules in lymphomononuclear cells of type 1 diabetes mellitus patients.
Fernandes AP; Foss MC; Donadi EA
Scand J Immunol; 2004 Mar; 59(3):305-9. PubMed ID: 15030582
[TBL] [Abstract][Full Text] [Related]
24. Allogenotypes defined by short DQ alpha and DQ beta cDNA probes correlate with and define splits of HLA-DQ serological specificities.
Bidwell JL; Bidwell EA; Laundy GJ; Klouda PT; Bradley BA
Mol Immunol; 1987 May; 24(5):513-22. PubMed ID: 2889137
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the N-linked glycopeptides of DQw1 and DR1 molecules.
Iturbe S; Narasimhan S; Merrick JM; Falk JA; Letarte M
J Immunol; 1986 Jun; 136(12):4588-95. PubMed ID: 3486905
[TBL] [Abstract][Full Text] [Related]
26. Structurally interdependent and independent regions of allelic polymorphism in class II MHC molecules. Implications for Ia function and evolution.
Braunstein NS; Germain RN; Loney K; Berkowitz N
J Immunol; 1990 Sep; 145(6):1635-45. PubMed ID: 1697304
[TBL] [Abstract][Full Text] [Related]
27. Identification of the DRw10 DR beta 1-chain allele as encoding a polymorphic class II major histocompatibility complex epitope otherwise restricted to DR beta 2 molecules of the DRw53 type.
Matsuyama T; Winchester R; Lee S; Shookster L; Nunez-Roldan A
J Immunol; 1988 Jan; 140(2):537-43. PubMed ID: 2447181
[TBL] [Abstract][Full Text] [Related]
28. Molecular diversity of HLA-DQ. DQ alpha and beta chain isoelectric point differences and their relation to serologically defined HLA-DQ allospecificities.
Bontrop RE; Baas EJ; Otting N; Schreuder GM; Giphart MJ
Immunogenetics; 1987; 25(5):305-12. PubMed ID: 3570381
[TBL] [Abstract][Full Text] [Related]
29. Implication of structural class II gene polymorphism for the concept of serologic specificities.
Möller E; Carlsson B; Wallin J
Immunol Rev; 1985 Jul; 85():107-28. PubMed ID: 2412948
[TBL] [Abstract][Full Text] [Related]
30. Evidence for a specific post-transcriptional mechanism controlling the expression of HLA-DQ, but not -DR and -DP, molecules.
De Lerma Barbaro A; Sartoris S; Tosi G; Nicolis M; Accolla RS
J Immunol; 1994 Nov; 153(10):4530-8. PubMed ID: 7525708
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T
J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957
[TBL] [Abstract][Full Text] [Related]
32. Human leukocyte antigen class II DQ alpha and beta epitopes identified from sera of kidney allograft recipients.
Deng CT; El-Awar N; Ozawa M; Cai J; Lachmann N; Terasaki PI
Transplantation; 2008 Aug; 86(3):452-9. PubMed ID: 18698250
[TBL] [Abstract][Full Text] [Related]
33. Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase.
Kwok WW; Domeier ML; Raymond FC; Byers P; Nepom GT
J Immunol; 1996 Mar; 156(6):2171-7. PubMed ID: 8690906
[TBL] [Abstract][Full Text] [Related]
34. Immunochemical analysis of the Ia polymorphisms among the family of DR7-associated HLA-D specificities.
Karr RW
J Immunol; 1986 Feb; 136(3):999-1006. PubMed ID: 3510255
[TBL] [Abstract][Full Text] [Related]
35. L cells expressing DQ molecules of the DR3 and DR4 haplotypes: reactivity patterns with mAbs.
Monos DS; Czanky E; Ono SJ; Radka SF; Kappes D; Strominger JL
Immunogenetics; 1995; 42(3):172-80. PubMed ID: 7642228
[TBL] [Abstract][Full Text] [Related]
36. Molecular complexity of HLA-DQw3: the TA10 determinant is located on a subset of DQw3 beta chains.
Radka SF; Scott RG; Stewart SJ
Hum Immunol; 1987 Apr; 18(4):287-300. PubMed ID: 2437090
[TBL] [Abstract][Full Text] [Related]
37. Analysis by molecular cloning of the human class II genes.
Erlich H; Stetler D; Sheng-Dong R; Saiki R
Fed Proc; 1984 Dec; 43(15):3025-30. PubMed ID: 6094260
[TBL] [Abstract][Full Text] [Related]
38. [Expression of class II HLA antigens (HLA-DR, DQW1, DQW3) in normal skin and cutaneous pathology].
Gomes M; Schmitt D; Dezutter-Dambuyant C; Capra JD; Thivolet J
Pathol Biol (Paris); 1986 Mar; 34(3):157-64. PubMed ID: 3517784
[TBL] [Abstract][Full Text] [Related]
39. Polymorphisms within the HLA-DR4 haplotypes. Various DQ subtypes detected with monoclonal antibodies.
Bontrop RE; Schreuder GM; Mikulski EM; van Miltenburg RT; Giphart MJ
Tissue Antigens; 1986 Jan; 27(1):22-31. PubMed ID: 3006281
[TBL] [Abstract][Full Text] [Related]
40. Replacement of the membrane proximal region of I-A(d) MHC class II molecule with I-E-derived sequences promotes production of an active and stable soluble heterodimer without altering peptide-binding specificity.
Chaves FA; Hou P; Wu S; Sant AJ
J Immunol Methods; 2005 May; 300(1-2):74-92. PubMed ID: 15896797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
